William Padula, PhD

Biography

William V. Padula, PhD is Associate Professor of Pharmaceutical & Health Economics at the University of Southern California Mann School of Pharmacy and Pharmaceutical Sciences and a Senior Scholar at the USC Schaeffer Institute for Public Policy & Government Service. His research advances economic evaluation methods to improve patient access, inform policy, and support efficient allocation of healthcare resources, with particular expertise in cost-effectiveness analysis, value-based decision making, real-world evidence, and health technology assessment.

Dr. Padula has authored more than 150 peer-reviewed publications and his work has been supported by the National Institutes of Health, the PhRMA Foundation, and the Bill & Melinda Gates Foundation, among other public and private partners. Through his work with the Gates Foundation, he co-edited the Handbook of the Applied Economics of Vaccines for Global Health (Oxford University Press), contributing to capacity building in immunization economics and health technology assessment in low- and middle-income country settings. His scholarship is especially known for bridging welfare economics with modern approaches to value measurement under uncertainty, including generalized cost-effectiveness analysis and dynamic modeling frameworks.

He serves as an Associate Editor of Value in Health and has held leadership roles with the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), including co-chairing the ISPOR Task Force on Machine Learning. He is a recipient of ISPOR’s Bernie J. O’Brien New Investigator Award and ISPOR’s Awards for Excellence in Health Economics and Outcomes Research (Methodology and Application). Dr. Padula also has nonprofit governance experience, including serving as President of the U.S. National Pressure Injury Advisory Panel (2021–2022) and as a Commissioner for the American Nurses Credentialing Center (ANCC) Magnet Recognition Program (2016–2019). He earned a BS in Chemical Engineering from Northwestern University, an MS in Evaluative Clinical Sciences from Dartmouth College, an MS in Data Analytics from the University of Chicago, and a PhD in Pharmaceutical Economics from the University of Colorado.